Publisher
Japanese Society on Thrombosis and Hemostasis
Reference15 articles.
1. 2) Pokorney SD, Simon DN, Thomas L, et al.: Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J 170: 141–148, 2015.
2. 3) Proietti M, Airaksinen KEJ, Rubboli A, et al.: Cundergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry. Am Heart J 190: 86–93, 2017.
3. 4) 日本循環器学会:2020年改訂版 不整脈薬物治療ガイドライン https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf(2022年2月24日閲覧)
4. 5) 辻肇:ヘパリン類の適正使用.血栓止血誌 19: 187–190, 2008.
5. 6) Wakui Y, Fujimori Y, Katagiri H, et al.: Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis. J Clin Pathol 72: 244–250, 2019.